Serum sAPO-1/Fas levels in multiple sclerosis-Reference-Cited by-同舟云学术

Serum sAPO-1/Fas levels in multiple sclerosis

Published:1997-04 Issue:4 Volume:95 Page:208-210
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:

Author:

Bansil S.,Holtz C. R.,Cook S. D.,Rohowsky-Kochan C.

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1997.tb00100.x/fullpdf

Reference8 articles.

1. The polypeptide encoded by the cDNA for human cell surface antigen FAS can mediate apoptosis;Itoh;Cell,1991

2. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells;Leithauser;Lab Invest,1993

3. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias;Knipping;Blood,1995

4. Protection from Fas-mediated apoptosis by a soluble form, of the Fas molecule;Cheng;Science,1994

5. New diagnostic criteria for multiple sclerosis: guidelines for research protocols;Poser;Ann Neurol,1983

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could Epstein-Barr Virus or Canine Distemper Virus Cause Multiple Sclerosis?;Neurologic Clinics;2008-08

2. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing—remitting multiple sclerosis;Multiple Sclerosis Journal;2008-01-21

3. CD95/Fas expression on peripheral blood T lymphocytes in patients with multiple sclerosis: effect of high-dose methylprednisolone therapy;Clinical Neurology and Neurosurgery;2004-06

4. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis;Clinical Neurology and Neurosurgery;2004-06

5. Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis;European Journal of Neurology;2002-01-20